DXCM vs PNTG · P/E 63, rev $2.50B vs P/E 40, rev $583.3M
DexCom Inc (DXCM) versus Pennant Group Inc (PNTG) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Pennant Group Inc (PNTG) is a medical care facilities company listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported PNTG revenue for 2026-06-30 was $583.3M. Net income was $17.6M. PNTG currently screens at market cap $1.20B and trailing P/E 40.2.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. PNTG currently screens at market cap $1.20B and trailing P/E 40.2.
Not investment advice. Open the DXCM and PNTG stock pages for the full models.
Not investment advice.